Can a Tight-Control strategy tame lupus?
NCT ID NCT05714930
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 'treat-to-target' approach—where doctors adjust treatment every 6 weeks to aim for remission—works better than usual care for people with lupus. About 606 participants who are not in remission will be followed for 120 weeks. The goal is to see if this strategy reduces long-term organ damage and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- treat-to-target strategy (tight control with frequent visits and treatment adjustments)
- What this could lead to
- If successful, this approach could become a standard way to manage lupus, helping more patients reach remission and prevent long-term organ damage.
- What could go wrong
- This is a strategy trial, not testing a new drug, so benefits may be modest. Results depend on how well doctors and patients follow the plan, and the study is still recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité - Berlin University of Medicine
RECRUITINGBerlin, 10117, Germany
-
Kliniken Essen Mitte, Essen
RECRUITINGEssen, North Rhine-Westphalia, 45136, Germany
-
LMU Munich
RECRUITINGMunich, Bavaria, 80336, Germany
-
Medical University Hannover
RECRUITINGHanover, Lower Saxony, 30625, Germany
-
Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum
RECRUITINGHerne, North Rhine-Westphalia, 44649, Germany
-
UKSH Campus Kiel
RECRUITINGKiel, 24105, Germany
-
University Clinic Düsseldorf
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
-
University Clinic Erlangen
NOT_YET_RECRUITINGErlangen, Bavaria, 91054, Germany
-
University Clinic Frankfurt
RECRUITINGFrankfurt am Main, Hesse, 60590, Germany
-
University Clinic Freiburg
RECRUITINGFreiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
University Clinic Heidelberg
RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
-
University Clinic Mainz
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
-
University Clinic Münster
RECRUITINGMünster, North Rhine-Westphalia, 48149, Germany
-
University Medical Center TU Dresden
RECRUITINGDresden, Saxony, 01307, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?